<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Učinkovitost in varnost alpeliziba pri zdravljenju HR+, HER2-, PIK3CA-mutiranega razsejanega raka dojk</dc:title><dc:creator>Godina,	Eva	(Avtor)
	</dc:creator><dc:creator>Ribnikar,	Domen	(Avtor)
	</dc:creator><dc:creator>Borštnar,	Simona	(Avtor)
	</dc:creator><dc:subject>onkologija</dc:subject><dc:subject>rak dojke</dc:subject><dc:subject>kemoterapija</dc:subject><dc:date>2022</dc:date><dc:date>2023-02-09 13:44:34</dc:date><dc:type>Neznano</dc:type><dc:identifier>16228</dc:identifier><dc:identifier>UDK: 618.1</dc:identifier><dc:identifier>COBISS_ID: 141115907</dc:identifier><dc:identifier>OceCobissID: 129701123</dc:identifier><dc:language>sl</dc:language></metadata>
